ARWR today
$49.36+$0.36 (+0.73%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourBullish
15 minSymmetric Triangle
5 minBullish
Daily trend turns up above $66.83
Key levels
Resistance$61.88
Resistance$56.56
Support$43.59
Support$40.29
Latest news & SEC filings
ProductArrowhead shares AHA 2026 results for plozasiran and ARO-DIMER-PA
DealArrowhead refinances debt with new $400M loan from Sixth Street
All ARWR news →About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA interference (RNAi) therapies that silence genes causing disease. Its approved product REDEMPLO treats familial chylomicronemia syndrome, and its pipeline targets cardiovascular, metabolic, liver, pulmonary, and neurological conditions. The company also licenses programs to partners such as Sarepta, Amgen, Takeda, GSK, and Novartis. It operates in the United States, Australia, New Zealand, and Ireland.
Based on the company's 10-K filed Nov 25, 2025.
Nasdaq · Healthcare
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
What Is the Price Target for ARWR?
SEPT Low Target
$46.00
SEPT Mid Target
$108.00
SEPT High Target
$123.00
Analyst Consensus
$108.00
Is ARWR a Buy or Sell Right Now?
Thesis
- •Revenue growing 23258.2% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ARWR.
Start Free Trial →Is ARWR Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$83.09
15
Moat Score
NONE
4/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with ARWR?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ARWR Growth Story
Revenue YoY
23258.2%
3yr Revenue CAGR
50.5%
EPS Growth YoY
99.8%
FCF Growth YoY
126.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for ARWR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ARWR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:12:14 | $49.33 | 14,200 | $$700K | SELL |
| 21:00:31 | $49.36 | 1,500 | $$74K | SELL |
| 21:00:31 | $49.36 | 1,600 | $$79K | SELL |
| 21:00:31 | $49.36 | 2,917 | $$144K | SELL |
| 21:00:31 | $49.36 | 1,127 | $$56K | SELL |
5 dark pool trades shown · $$1.1M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ARWR
PREVIEWSEPT Investing provides real-time options flow tracking for ARWR, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $45 | Dec 18 | 37 | $$2300 | 10 | SWEEP |
| CALL | $50 | Dec 18 | 37 | $$1800 | 5 | SWEEP |
| CALL | $50 | Dec 18 | 37 | $$1440 | 4 | SWEEP |
| CALL | $50 | Dec 18 | 37 | $$1440 | 4 | SWEEP |
| CALL | $50 | Dec 18 | 37 | $$1110 | 3 | SWEEP |
5 options trades shown · 80% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About ARWR
3 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ARWR. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $ARWR (ARROWHEAD PHARMACEUTICALS, INC.) Price: $62.75 | Zone: $60.44 — $62.99 Conviction: LOW | Analyst upside: +56.2% Major volume event today — setup forming. No recent news — technic...
Zone Setup -- $ARWR (ARROWHEAD PHARMACEUTICALS, INC.) Price: $85.54 | Zone: $69.95 to $95.49 Conviction: HIGH | Analyst upside: +15.2% Near resistance (61% of range) — breakout watch. Strong positiv...
Zone Setup -- $ARWR (ARROWHEAD PHARMACEUTICALS, INC.) Price: $85.62 | Zone: $69.95 to $95.49 Conviction: HIGH | Analyst upside: +12.3% Near resistance (61% of range) — breakout watch. Strong positiv...
Join 3,500+ traders discussing ARWR in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ARWR — frequently asked questions
What is ARWR stock price today?
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) is at $49.36, up 0.73% (+$0.36) at the Nov 11, 2026 close.
Why is ARWR stock moving today?
Latest ARWR news — Nov 9, 2026: Arrowhead shares AHA 2026 results for plozasiran and ARO-DIMER-PA · Nov 4, 2026: Arrowhead refinances debt with new $400M loan from Sixth Street
What is the ARWR price target?
The average analyst price target for ARWR is $108.00, ranging from $46 to $123, based on 11 analysts.
What do analysts rate ARWR?
Analyst ratings for ARWR: 0 Buy, 16 Hold, 0 Sell — consensus Hold.
Does ARWR pay a dividend?
ARWR does not currently pay a dividend.
What are ARWR support and resistance levels?
Support: $43.59, $40.29, $37.06. Resistance: $56.56, $61.88, $66.83.
What are insiders doing with ARWR?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on ARWR?
Nov 9, 2026: Arrowhead shares AHA 2026 results for plozasiran and ARO-DIMER-PA · Nov 4, 2026: Arrowhead refinances debt with new $400M loan from Sixth Street